Cargando…
Discovery and validation of a novel blood‐based molecular biomarker of rejection following liver transplantation
Noninvasive biomarker profiles of acute rejection (AR) could affect the management of liver transplant (LT) recipients. Peripheral blood was collected following LT for discovery (Northwestern University [NU]) and validation (National Institute of Allergy and Infectious Diseases Clinical Trials in Or...
Autores principales: | Levitsky, Josh, Asrani, Sumeet K., Schiano, Thomas, Moss, Adyr, Chavin, Kenneth, Miller, Charles, Guo, Kexin, Zhao, Lihui, Kandpal, Manoj, Bridges, Nancy, Brown, Merideth, Armstrong, Brian, Kurian, Sunil, Demetris, Anthony J., Abecassis, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496674/ https://www.ncbi.nlm.nih.gov/pubmed/32356368 http://dx.doi.org/10.1111/ajt.15953 |
Ejemplares similares
-
Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature
por: Levitsky, Josh, et al.
Publicado: (2021) -
Gene expression biomarkers for kidney transplant rejection – The entire landscape
por: Friedewald, John, et al.
Publicado: (2019) -
Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients
por: Bhat, Mamatha, et al.
Publicado: (2022) -
The Continued Impact of Acute Rejection in the Last Decade of Liver Transplantation
por: HARRINGTON, C. R., et al.
Publicado: (2022) -
Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)